首页> 外文期刊>American Journal of Pathology: Official Publication of the American Association of Pathologists >Global and Targeted miRNA Expression Profiling in Clear Cell Renal Cell Carcinoma Tissues Potentially Links miR-155-5p and miR-210-3p to both Tumorigenesis and Recurrence
【24h】

Global and Targeted miRNA Expression Profiling in Clear Cell Renal Cell Carcinoma Tissues Potentially Links miR-155-5p and miR-210-3p to both Tumorigenesis and Recurrence

机译:透明细胞肾细胞癌组织中的全局和靶向 miRNA 表达谱可能将 miR-155-5p 和 miR-210-3p 与肿瘤发生和复发联系起来

获取原文
获取原文并翻译 | 示例

摘要

About 30 of patients undergoing nephrectomy for renal cell carcinoma (RCC) experience disease recurrence. We profiled miRNAs dysregulated in clear-cell (cc) RCC tumor tissues and predictive of recurrence. The expression levels of 800 miRNAs were assessed in paired tumor and normal tissues from a discovery cohort of 18 ccRCC patients. miRNAs found to be differentially expressed were examined in a validation set of 205 patients, using real-time quantitative PCR. Tumor-normal data from 64 patients in The Cancer Genome Atlas were used for external validation. Twenty-eight miRNAs were consistently dysregulated in tumor tissues. On dichotomized analysis, patients with high levels of miR-155-5p and miR-210-3p displayed an increased risk for ccRCC recurrence (hazard ratio, 2.64; 95 CI, 1.49 to 4.70;P?=?0.0009; and hazard ratio, 1.80; 95 CI, 1.04 to 3.12;P?=?0.036, respectively) and a shorter median recurrence-free survival time than did patients with low levels P?
机译:大约 30% 因肾细胞癌 (RCC) 而接受肾切除术的患者会出现疾病复发。我们分析了透明细胞 (cc) RCC 肿瘤组织中失调并预测复发的 miRNA。在 18 名 ccRCC 患者的发现队列中评估了 800 个 miRNA 在配对肿瘤和正常组织中的表达水平。使用实时定量PCR在205名患者的验证集中检查了差异表达的miRNA。癌症基因组图谱中 64 名患者的肿瘤正常数据用于外部验证。28 个 miRNA 在肿瘤组织中持续失调。在二分类分析中,miR-155-5p 和 miR-210-3p 水平高的患者发生 ccRCC 复发的风险增加(风险比 2.64;95% CI 为 1.49-4.70;P?=?0.0009;风险比为1.80;95% CI,1.04-3.12;P?=?0.036)和中位无复发生存时间比低水平患者更短[P?0.01(log秩检验)]。根据miR-155-5p和miR-210-3p的表达水平进行风险评分,趋势检验具有显著性(P?=?0.005)。在通路分析中,miR-155-5p和miR-210-3p调控的靶基因主要富集于炎症相关通路中。我们鉴定并验证了ccRCC组织中失调的多种miRNA;miR-155-5p 和 miR-210-3p 可预测 ccRCC 复发,指出其作为生物标志物和潜在生物学机制的潜在效用。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号